Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Enveric Biosciences Announces MagicMed Industries' Presentations at the Following Investor Conferences in September

/PRNewswire/ --  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced...

ENVB : 2.65 (-10.77%)
Should Enveric Biosciences be in Your Stock Portfolio?

Enveric Biosciences (ENVB) garnered significant market attention, announcing its proposed acquisition of MagicMed in May 2021. However, is it smart to bet on the stock now, as it has yet to generate revenue?...

ENVB : 2.65 (-10.77%)
Enveric Biosciences CEO, David Johnson, Issues Letter to Shareholders

/PRNewswire/ -- (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel therapeutic drugs to improve the quality of life for cancer patients, Chief Executive...

ENVB : 2.65 (-10.77%)
New CBD Trials Point the Way for Enveric, MagicMed

Whitefish, Montana--(Newsfile Corp. - August 2, 2021) - (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries,...

ENVB : 2.65 (-10.77%)
CNFN : 0.0851 (-5.44%)
Enveric Bio's Acquisition of MagicMed Accentuates Strengths of Each Company

Whitefish, Montana--(Newsfile Corp. - July 12, 2021) -   (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries,...

ENVB : 2.65 (-10.77%)
CNFN : 0.0851 (-5.44%)
Enveric Biosciences Announces Approval from Israel's Ministry of Health to Begin its Phase 1/2 Trial of Triple-Combination CBD Treatment for Glioblastoma

/PRNewswire/ --  (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced today that...

ENVB : 2.65 (-10.77%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates ARPO, ALTA, ENVB, FBNC, MCF; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ARPO : 2.20 (-0.90%)
ALTA : 40.57 (+2.17%)
ENVB : 2.65 (-10.77%)
FBNC : 39.61 (+1.83%)
MCF : 3.94 (+6.20%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Enveric Biosciences, Inc. - ENVB

/PRNewswire/ --

ENVB : 2.65 (-10.77%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CNST, FMBI, SWN, ENVB, MLND; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CNST : 33.99 (+0.06%)
FMBI : 17.90 (+1.42%)
SWN : 5.38 (+4.26%)
ENVB : 2.65 (-10.77%)
MLND : 15.9000 (-5.36%)
Lifshitz Law Firm, P.C. Announces Investigation of CLDR, DTRCD, DCRN, ENVB, PACX, SNX, XERS, and SBBP

/PRNewswire/ --

CLDR : 15.93 (unch)
DTRCD : 5.6500 (-2.85%)
DCRN : 9.89 (unch)
ENVB : 2.65 (-10.77%)
PACX : 9.95 (-0.10%)
SNX : 118.67 (+2.10%)
XERS : 2.55 (-2.67%)
SBBP : 2.11 (-2.76%)

Barchart Exclusives

Lumber: The Power of "S"
The rise and fall of the lumber market over the last year was historic, with the next move looking to already be under way. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar